Cardionovum

Be up
to date.

Latest press release

RESTORE clinical study results on in-stent restenosis.

Cardionovum experiences increase in demand for its innovative, and next generation „RESTORE Paclitaxel-releasing coronary balloon dilatation catheter.“ The American Journal of Cardiology, issue December 2015, published study results on the efficacy and safety of Paclitaxel coated balloon catheters for the treatment of in-stent restenosis in high risk patients. The RESTORE DEB showed significant superiority with lowest incidence of restenosis, if compared to other contemporary coronary DEBs.

Learn more >>

Cardionovum at LINC 2016

Dr. Jean Paul de Vries (PI) presented the patient study results of the multi-center randomized RAPID trial.

Learn more >>

Early APERTO patient results look promising.

Cardionovum prepares for a first international publication on 6-12 months FU patient results from the ongoing APERTO clinical study program. The APERTO Paclitaxel-releasing high pressure shunt balloon dilatation catheter was exclusively designed to treat shunt stenosis of hemodialysis patients.

Learn more >>

Upcoming events

Cardionovum® at DEBS 2025

Cardionovum® is pleased to invite you to visit us at booth #4.

Location:

NH Collection Vittorio Veneto
Corso d’Italia 1,
00198 Rome
Italy

Date: Jan 30, 2025–Jan 31, 2025

Latest events

Cardionovum at EuroPCR

Cardionovum participates at EuroPCR 2019
You are welcome to visit us at booth no. M 7 (level 2)

Date: May 21, 2019–May 25, 2019

Location: Paris, France

Visit website >>

Cardionovum at CIRSE

Cardionovum participates at CIRSE 2018

Date: Sep 22, 2018–Sep 26, 2018

Location: Lisbon, Portugal

Visit website >>

Cardionovum at EuroPCR

Cardionovum participates at EuroPCR 2018
You are welcome to visit us at booth no. M 47 (level 2)

Date: May 22, 2018–May 26, 2018

Location: Paris, France

Learn more >>

Visit website >>

go top